Risedronate Sodium
CAS 115436-72-1 7 FDA-DMF suppliersSmall Molecule
Overview
Risedronate Sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It works by inhibiting bone resorption and modifying the bone turnover cycle.
API suppliers (9)
Suppliers of Risedronate Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- TAPI NL BV1 active DMF
- TAPI NL BV1 active DMF
- TAPI NL BV1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
- TAPI NL BV1 active DMF
- TAPI NL BV1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF
- DPT Laboratories, Ltd.United States
Therapeutic areas
Bone DiseasesOsteoporosisPaget's Disease
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.